Related Experiment Video
Updated: Jul 9, 2026
08:15
Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
VEGF as a potential target for therapeutic intervention in depression
Jennifer L Warner-Schmidt1, Ronald S Duman
1The Rockefeller University, 1230 York Avenue, New York, NY 10065, USA. jschmidt@rockefeller.edu
Current Opinion in Pharmacology
|December 7, 2007
Summary
Antidepressant mechanisms remain unclear, but vascular endothelial growth factor (VEGF) shows promise. This study explores VEGF
Area of Science:
- Neuroscience
- Molecular Biology
- Pharmacology
Background:
- Antidepressants are widely used, yet their precise mechanism of action is unknown.
- Neurotrophic factors are emerging as key targets for novel antidepressant therapies.
- Vascular Endothelial Growth Factor (VEGF) has been implicated in cellular and behavioral responses to antidepressants.
Purpose of the Study:
- To investigate the role of VEGF in the efficacy of antidepressant treatments.
- To understand the molecular and cellular specificity of antidepressant-induced VEGF.
- To evaluate VEGF as a potential therapeutic target for depression.
Main Methods:
- Characterization of VEGF's role in antidepressant responses.
- Analysis of VEGF's function as a mitogen and survival factor for endothelial cells and neurons.
- Assessment of VEGF's modulation of synaptic transmission.
Main Results:
- VEGF plays a significant role in cellular and behavioral antidepressant effects.
- VEGF acts as a potent mitogen and survival factor for endothelial cells and neurons.
- VEGF influences synaptic transmission, a key process in mood regulation.
Conclusions:
- Understanding antidepressant-induced VEGF is crucial for developing targeted depression therapies.
- VEGF represents a promising therapeutic target for treating depression.
- Further research into VEGF's specific roles may unlock new antidepressant strategies.
Related Concept Videos
01:18Depression: Overview
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
01:27Depressive Disorders: Etiology
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
01:25Antidepressant Drugs: Overview
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
01:24Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
01:16TGF - β Signaling Pathway
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...